应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01763 中国同辐
已收盘 05-16 16:08:09
11.200
-0.020
-0.18%
最高
11.260
最低
10.960
成交量
17.20万
今开
11.200
昨收
11.220
日振幅
2.67%
总市值
35.83亿
流通市值
8.96亿
总股本
3.20亿
成交额
190.94万
换手率
0.22%
流通股本
7,997万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
中核在玉林成立新公司 注册资本5000万
天眼查 · 17:09
中核在玉林成立新公司 注册资本5000万
中国同辐(01763)上涨5.15%,报11.02元/股
金融界 · 05-09
中国同辐(01763)上涨5.15%,报11.02元/股
中国同辐盘中异动 下午盘股价大涨5.15%报11.021港元
自选股智能写手 · 05-09
中国同辐盘中异动 下午盘股价大涨5.15%报11.021港元
中国同辐将于8月13日派发末期股息每股0.3131元
新浪港股 · 05-08
中国同辐将于8月13日派发末期股息每股0.3131元
中国同辐(01763):2024年末期股息每股0.3131元
和讯 · 05-07
中国同辐(01763):2024年末期股息每股0.3131元
中国同辐(01763)将于8月13日派发末期股息每股0.3131元
智通财经 · 05-07
中国同辐(01763)将于8月13日派发末期股息每股0.3131元
中国同辐(01763.HK)总经理变更
阿斯达克财经 · 05-07
中国同辐(01763.HK)总经理变更
中国同辐(01763)委任汪尧为公司总经理
智通财经 · 05-06
中国同辐(01763)委任汪尧为公司总经理
港股概念追踪 |中国掌握批量化在线辐照生产同位素关键技术 核药产业受关注(附概念股)
媒体滚动 · 05-03
港股概念追踪 |中国掌握批量化在线辐照生产同位素关键技术 核药产业受关注(附概念股)
中国同辐(01763)上涨5.06%,报10.8元/股
金融界 · 04-26
中国同辐(01763)上涨5.06%,报10.8元/股
中国同辐盘中异动 急速上涨5.07%
自选股智能写手 · 04-26
中国同辐盘中异动 急速上涨5.07%
中国同辐(01763)股价上升5.058%,现价港币$10.8
阿斯达克财经 · 04-26
中国同辐(01763)股价上升5.058%,现价港币$10.8
港股异动 | 中国同辐(01763)涨超4% 中核高通正式具备万居里GMP级镥-177等核素生产供应能力
智通财经 · 04-23
港股异动 | 中国同辐(01763)涨超4% 中核高通正式具备万居里GMP级镥-177等核素生产供应能力
中国同辐(01763)股价上升5.061%,现价港币$10.38
阿斯达克财经 · 04-23
中国同辐(01763)股价上升5.061%,现价港币$10.38
中国同辐(01763):中核高通正式具备万居里GMP级镥-177等核素生产供应能力
智通财经网 · 04-22
中国同辐(01763):中核高通正式具备万居里GMP级镥-177等核素生产供应能力
中国同辐(01763.HK)旗下附属产品符合欧洲药管局要求
阿斯达克财经 · 04-22
中国同辐(01763.HK)旗下附属产品符合欧洲药管局要求
中国同辐(01763)上涨10.05%,报10.18元/股
金融界网站 · 04-22
中国同辐(01763)上涨10.05%,报10.18元/股
港股异动 | 中国同辐(01763)盘中涨超7% 碳-14同位素实现供应全面国产化
智通财经 · 04-22
港股异动 | 中国同辐(01763)盘中涨超7% 碳-14同位素实现供应全面国产化
中国同辐(01763)股价上升6.811%,现价港币$9.88
阿斯达克财经 · 04-22
中国同辐(01763)股价上升6.811%,现价港币$9.88
港股概念追踪 |中国首次批量生产碳-14同位素 国产核药迎来新机遇(附概念股)
智通财经 · 04-22
港股概念追踪 |中国首次批量生产碳-14同位素 国产核药迎来新机遇(附概念股)
加载更多
公司概况
公司名称:
中国同辐
所属市场:
SEHK
上市日期:
--
主营业务:
中国同辐股份有限公司是一家主要从事诊断及治疗用放射性药品以及医用与工业用放射源产品的研究、开发、制造和销售业务的中国公司。该公司还提供辐照灭菌服务,并从事伽玛射线辐照装置的设计、制造和安装业务。该公司包括药品、放射源产品、辐照和独立医学检验实验室服务及其他业务四个业务部门,其中药品部门为其核心部门。药品部门主要从事影像诊断及治疗用放射性药品、尿素呼气试验药盒及测试仪以及体外免疫诊断试剂及药盒的研发、制造和销售业务。
发行价格:
--
{"stockData":{"symbol":"01763","market":"HK","secType":"STK","nameCN":"中国同辐","latestPrice":11.2,"timestamp":1715846889029,"preClose":11.22,"halted":0,"volume":172000,"delay":0,"floatShares":79968800,"shares":319874900,"eps":1.2535154,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.02,"latestTime":"05-16 16:08:09","open":11.2,"high":11.26,"low":10.96,"amount":1909400,"amplitude":0.026738,"askPrice":11.28,"askSize":400,"bidPrice":11.2,"bidSize":33400,"shortable":0,"etf":0,"ttmEps":1.2535153053220633,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715909400000},"adr":0,"listingDate":1530806400000,"adjPreClose":11.22,"dividendRate":0.030244,"openAndCloseTimeList":[[1715823000000,1715832000000],[1715835600000,1715846400000]],"volumeRatio":0.695204,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01763","defaultTab":"news","newsList":[{"id":"2435627826","title":"中核在玉林成立新公司 注册资本5000万","url":"https://stock-news.laohu8.com/highlight/detail?id=2435627826","media":"天眼查","top":-1,"share":"https://www.laohu8.com/m/news/2435627826?lang=zh_cn&edition=full","pubTime":"2024-05-16 17:09","pubTimestamp":1715850542,"startTime":"0","endTime":"0","summary":"(原标题:中核在玉林成立新公司 注册资本5000万)天眼查App显示,近日,中核(玉林)辐照有限公司成立,法定代表人为杨哲,注册资本5000万人民币,经营范围含合成材料销售,电线、电缆经营,供销合作社管理服务,道路货物运输站经营等。股东信息显示,该公司由中核集团旗下中国同辐(HK.01763)、中核海南核电有限公司分别持股51%、49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405161733498b0e6847&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405161733498b0e6847&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434505968","title":"中国同辐(01763)上涨5.15%,报11.02元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2434505968","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2434505968?lang=zh_cn&edition=full","pubTime":"2024-05-09 14:36","pubTimestamp":1715236598,"startTime":"0","endTime":"0","summary":"5月9日,中国同辐盘中上涨5.15%,截至14:36,报11.02元/股,成交129.23万元。中国同辐股份有限公司的主营业务为同位素制品和辐照加工,强化主业并致力于研发和市场拓展,以打造成为同位素及辐照加工行业的龙头企业。公司于2011年12月6日注册成立,注册资金23990.61万元,现有员工近2000人,是由中国核工业集团公司、中国原子能科学研究院和中国核动力研究设计院共同出资创建。截至2023年年报,中国同辐营业总收入66.35亿元、净利润3.71亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/09143640579525.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434581420","title":"中国同辐盘中异动 下午盘股价大涨5.15%报11.021港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434581420","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434581420?lang=zh_cn&edition=full","pubTime":"2024-05-09 13:36","pubTimestamp":1715232976,"startTime":"0","endTime":"0","summary":"2024年05月09日下午盘13时36分,中国同辐股票出现波动,股价快速拉升5.15%。截至发稿,该股报11.021港元/股,成交量7.32万股,换手率0.09%,振幅5.15%。资金方面,该股资金流入42.1788万港元,流出33.6504万港元。中国同辐股票所在的药品行业中,整体涨幅为0.16%。其相关个股中,中国生物制药、长江生命科技、华控康泰涨幅较大,振幅较大的相关个股有君圣泰医药-B、前海健康、三爱健康集团,振幅分别为21.34%、7.69%、7.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509133616861ec0b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509133616861ec0b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433750232","title":"中国同辐将于8月13日派发末期股息每股0.3131元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433750232","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2433750232?lang=zh_cn&edition=full","pubTime":"2024-05-08 08:44","pubTimestamp":1715129064,"startTime":"0","endTime":"0","summary":"中国同辐(01763)发布公告,该公司将于2024年8月13日派发末期股息每股0.3131元。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-05-08/doc-inaunpfa9645171.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-05-08/doc-inaunpfa9645171.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433789533","title":"中国同辐(01763):2024年末期股息每股0.3131元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433789533","media":"和讯","top":-1,"share":"https://www.laohu8.com/m/news/2433789533?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:53","pubTimestamp":1715093583,"startTime":"0","endTime":"0","summary":" 中国同辐已宣布,将于2024年8月13日向股东派发每股0.3131元的末期股息。投资者可以期待在2024年8月13日收到来自中国同辐的股息。这一派息计划将进一步增强投资者对中国同辐的信心,并对公司的长期投资价值产生积极影响。中国同辐在公告中并未提及此次派息对公司未来财务状况的影响。值得注意的是,中国同辐此次派息的具体金额可能会受到市场和公司业绩等因素的影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722535187dccd22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722535187dccd22&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433035022","title":"中国同辐(01763)将于8月13日派发末期股息每股0.3131元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433035022","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433035022?lang=zh_cn&edition=full","pubTime":"2024-05-07 20:09","pubTimestamp":1715083747,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国同辐(01763)发布公告,该公司将于2024年8月13日派发末期股息每股0.3131元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1118422.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433694522","title":"中国同辐(01763.HK)总经理变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2433694522","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2433694522?lang=zh_cn&edition=full","pubTime":"2024-05-07 09:26","pubTimestamp":1715045160,"startTime":"0","endTime":"0","summary":"中国同辐(01763.HK) 公布,许红超因工作职务调整原因而辞任公司执行董事、董事会战略委员会委员、科技创新委员会委员,自股东大会批准委任汪尧为执行董事起生效。许红超亦辞任总经理职务,由汪尧接任,自5月6日起生效。(cy/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220412153213134_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220412153213134_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1347668/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2433547803","title":"中国同辐(01763)委任汪尧为公司总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2433547803","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433547803?lang=zh_cn&edition=full","pubTime":"2024-05-06 20:53","pubTimestamp":1715000009,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中国同辐 发布公告,许红超先生因工作职务调整原因而辞任公司执行董事、董事会战略委员会委员、科技创新委员会委员,自公司股东在股东大会上批准委任汪尧先生为公司执行董事起生效。董事会亦决议委任汪尧先生为公司总经理,任期自2024年5月6日起至第四届董事会任期届满之日止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1117862.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432995389","title":"港股概念追踪 |中国掌握批量化在线辐照生产同位素关键技术 核药产业受关注(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2432995389","media":"媒体滚动","top":-1,"share":"https://www.laohu8.com/m/news/2432995389?lang=zh_cn&edition=full","pubTime":"2024-05-03 09:21","pubTimestamp":1714699260,"startTime":"0","endTime":"0","summary":"5月1日21时18分,经过二十一天的奋战,中核集团旗下中国核电投资控股的秦山核电在线辐照生产医用同位素装置顺利完成系统标识和送电试验,标志着该套装置已按计划全面建成,至此,我国掌握了批量化在线辐照生产同位素的关键技术,镥-177、锶-89和钇-90等多种国内当前紧缺的短半衰期医用同位素将在今年下半年配套厂房建成投产后进入规模化生产阶段。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-03/doc-inatxcqa7962160.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-05-03/doc-inatxcqa7962160.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430216259","title":"中国同辐(01763)上涨5.06%,报10.8元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430216259","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430216259?lang=zh_cn&edition=full","pubTime":"2024-04-26 13:28","pubTimestamp":1714109338,"startTime":"0","endTime":"0","summary":"4月26日,中国同辐(01763)盘中上涨5.06%,截至13:28,报10.8元/股,成交431.17万元。中国同辐股份有限公司的主营业务为同位素制品和辐照加工,强化主业并致力于研发和市场拓展,以打造成为同位素及辐照加工行业的龙头企业。公司于2011年12月6日注册成立,注册资金23990.61万元,现有员工近2000人,是由中国核工业集团公司、中国原子能科学研究院和中国核动力研究设计院共同出资创建。截至2023年年报,中国同辐营业总收入66.35亿元、净利润3.71亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/26132840425608.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430219982","title":"中国同辐盘中异动 急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430219982","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430219982?lang=zh_cn&edition=full","pubTime":"2024-04-26 13:28","pubTimestamp":1714109332,"startTime":"0","endTime":"0","summary":"2024年04月26日下午盘13时28分,中国同辐股票出现波动,股价快速拉升5.07%。截至发稿,该股报10.801港元/股,成交量41.64万股,换手率0.52%,振幅6.61%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。中国同辐股票所在的药品行业中,整体涨幅为0.31%。其相关个股中,康龙化成、凯莱英、中国同辐涨幅较大,振幅较大的相关个股有三爱健康集团、开拓药业-B、海王英特龙,振幅分别为13.79%、10.64%、10.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426132852861e9721&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426132852861e9721&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430219568","title":"中国同辐(01763)股价上升5.058%,现价港币$10.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2430219568","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430219568?lang=zh_cn&edition=full","pubTime":"2024-04-26 13:25","pubTimestamp":1714109100,"startTime":"0","endTime":"0","summary":"[上升股]中国同辐(01763) 股价在下午01:25比前收市价上升5.058%,现股价为港币$10.8。至目前为止,今日最高价为$10.8,而最低价为$10.12。总成交量为39.82万股,总成交金额为港币$411.548万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404263881/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2429562661","title":"港股异动 | 中国同辐(01763)涨超4% 中核高通正式具备万居里GMP级镥-177等核素生产供应能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2429562661","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429562661?lang=zh_cn&edition=full","pubTime":"2024-04-23 14:49","pubTimestamp":1713854971,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中国同辐涨超4%,截至发稿,涨3.85%,报10.26港元,成交额122.88万港元。消息面上,中国同辐发公告称,近日,国内首条年产万居里级无载体镥-177 GMP生产线、年产能千条级锗镓68Ge-68Ga发生器生产线全面建成投产,标志着国产化大规模商业化供应GMP级镥-177、镓-68两款医用核素真正实现。后续中核高通将进军国际市场,参与国际医用核素产业链大循环。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107415.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429155755","title":"中国同辐(01763)股价上升5.061%,现价港币$10.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2429155755","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429155755?lang=zh_cn&edition=full","pubTime":"2024-04-23 14:20","pubTimestamp":1713853200,"startTime":"0","endTime":"0","summary":"[上升股]中国同辐(01763) 股价在下午02:20比前收市价上升5.061%,现股价为港币$10.38。至目前为止,今日最高价为$10.38,而最低价为$9.95。总成交量为10.58万股,总成交金额为港币$106.607万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404233312/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2429912053","title":"中国同辐(01763):中核高通正式具备万居里GMP级镥-177等核素生产供应能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2429912053","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2429912053?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:52","pubTimestamp":1713775922,"startTime":"0","endTime":"0","summary":"中国同辐(01763)发布公告,近日,国内首条年产万居里级无载体镥-177 \nGM...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_22.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_22.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106514.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429291761","title":"中国同辐(01763.HK)旗下附属产品符合欧洲药管局要求","url":"https://stock-news.laohu8.com/highlight/detail?id=2429291761","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429291761?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:51","pubTimestamp":1713775860,"startTime":"0","endTime":"0","summary":"中国同辐(01763.HK) 公布,旗下附属公司成都中核高通同位素股份有限公司的镥-177及镓-68两款产品,在产线设计、生产技术、质量指标、设备设施、管理体系等方面均符合欧洲药品管理局(EMA)标准要求。公司透露,中核高通后续将进军国际市场,并参与国际医用核素产业链大循环。公告亦指,中核高通可正式供应居里级的铽-161、钪-47 两款新星核素。(js/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20181003134250135_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20181003134250135_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1343997/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2429993789","title":"中国同辐(01763)上涨10.05%,报10.18元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429993789","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2429993789?lang=zh_cn&edition=full","pubTime":"2024-04-22 11:40","pubTimestamp":1713757200,"startTime":"0","endTime":"0","summary":"转自:金融界本文源自:金融界4月22日,中国同辐(01763)盘中上涨10.05%,截至11:35,报10.18元/股,成交457.69万元。中国同辐股份有限公司的主营业务为同位素制品和辐照加工,强化主业并致力于研发和市场拓展,以打造成为同位素及辐照加工行业的龙头企业。公司于2011年12月6日注册成立,注册资金23990.61万元,现有员工近2000人,是由中国核工业集团公司、中国原子能科学研究院和中国核动力研究设计院共同出资创建。截至2023年年报,中国同辐营业总收入66.35亿元、净利润3.71亿元。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-04-22/doc-inassmrc3467083.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-04-22/doc-inassmrc3467083.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429960479","title":"港股异动 | 中国同辐(01763)盘中涨超7% 碳-14同位素实现供应全面国产化","url":"https://stock-news.laohu8.com/highlight/detail?id=2429960479","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429960479?lang=zh_cn&edition=full","pubTime":"2024-04-22 11:00","pubTimestamp":1713754813,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中国同辐盘中涨超7%,截至发稿,涨6.49%,报9.85港元,成交额356.44万港元。消息面上,4月20日,中核集团宣布我国首次成功利用核电站商用堆批量生产碳-14同位素实现碳-14供应全面国产化。据介绍,利用商用重水堆辐照生产碳-14,是秦山核电建设的首个医用同位素项目,生产技术也属于国内首创。据悉,本次碳-14靶件出堆经分离提纯后将于2024年底开始向市场供货,产量可充分满足国内需求,这将有力带动我国同位素应用产业链发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106319.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429964349","title":"中国同辐(01763)股价上升6.811%,现价港币$9.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2429964349","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429964349?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:50","pubTimestamp":1713750600,"startTime":"0","endTime":"0","summary":"[上升股]中国同辐(01763) 股价在上午09:50比前收市价上升6.811%,现股价为港币$9.88。至目前为止,今日最高价为$9.88,而最低价为$9.5。总成交量为6.46万股,总成交金额为港币$61.841万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404222104/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2429696599","title":"港股概念追踪 |中国首次批量生产碳-14同位素 国产核药迎来新机遇(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2429696599","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429696599?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:08","pubTimestamp":1713748107,"startTime":"0","endTime":"0","summary":"4月20日13时48分,经过两年的堆芯辐照后,第一根碳-14靶件从中核集团旗下中国核电投资控股的秦山核电重水堆机组中成功出堆,这是我国首次批量生产碳-14同位素,破解了国内碳-14同位素依赖进口的难题,实现碳-14供应全面国产化。碳-14是碳元素的一种具有放射性的同位素,被广泛作为示踪剂使用,幽门螺旋杆菌检测是其最具代表性的用途。此前,我国碳-14供应几乎全部依赖进口,价格昂贵且供应得不到保障,这已成为下游产业发展的制约因素。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106265.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-isotope.com","stockEarnings":[{"period":"1week","weight":0.0466},{"period":"1month","weight":0.1368},{"period":"3month","weight":0.0036},{"period":"6month","weight":-0.1487},{"period":"1year","weight":-0.3686},{"period":"ytd","weight":-0.1602}],"compareEarnings":[{"period":"1week","weight":0.0322},{"period":"1month","weight":0.1407},{"period":"3month","weight":0.2012},{"period":"6month","weight":0.0696},{"period":"1year","weight":-0.0449},{"period":"ytd","weight":0.1189}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国同辐股份有限公司是一家主要从事诊断及治疗用放射性药品以及医用与工业用放射源产品的研究、开发、制造和销售业务的中国公司。该公司还提供辐照灭菌服务,并从事伽玛射线辐照装置的设计、制造和安装业务。该公司包括药品、放射源产品、辐照和独立医学检验实验室服务及其他业务四个业务部门,其中药品部门为其核心部门。药品部门主要从事影像诊断及治疗用放射性药品、尿素呼气试验药盒及测试仪以及体外免疫诊断试剂及药盒的研发、制造和销售业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.039658},{"month":2,"riseRate":0.5,"avgChangeRate":0.043927},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.041563},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.010276},{"month":5,"riseRate":0.666667,"avgChangeRate":0.016108},{"month":6,"riseRate":0.4,"avgChangeRate":0.02961},{"month":7,"riseRate":0.4,"avgChangeRate":-0.045882},{"month":8,"riseRate":0.5,"avgChangeRate":0.033069},{"month":9,"riseRate":0,"avgChangeRate":-0.046173},{"month":10,"riseRate":0.5,"avgChangeRate":-0.084633},{"month":11,"riseRate":0.833333,"avgChangeRate":0.072515},{"month":12,"riseRate":0.666667,"avgChangeRate":0.011117}],"exchange":"SEHK","name":"中国同辐","nameEN":"CIRC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国同辐,01763,中国同辐股票,中国同辐股票老虎,中国同辐股票老虎国际,中国同辐行情,中国同辐股票行情,中国同辐股价,中国同辐股市,中国同辐股票价格,中国同辐股票交易,中国同辐股票购买,中国同辐股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国同辐(01763)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国同辐(01763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}